Physician profile
Stephen E Durand
NPI 1265584411
$5,285.96
in general payments reported to CMS, 2019-2025
17 companies · $1,230 in 2025
The $1,230 reported for 2025 was more than what 99% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $712 · 2022: $1,270 · 2023: $1,283 · 2024: $792 · 2025: $1,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,304.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $1,416.91 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,142.96 | 2022-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $1,065.67 | 2021-2025 | Spravato |
| Abbvie INC. | $608.47 | 2021-2025 | |
| Axsome Therapeutics, INC. | $203.93 | 2022-2025 | Auvelity |
| Alkermes, INC. | $184.34 | 2021-2023 | Aristada, Aristada Initio |
| Fisher & Paykel Healthcare INC | $178.23 | 2025 | Fisher & Paykel Healthcare |
| Jazz Pharmaceuticals INC. | $121.82 | 2022 | |
| Almatica Pharma LLC | $109.62 | 2022-2025 | Loreev Xr, Sertraline Hcl |
| Takeda Pharmaceuticals U.S.A., INC. | $86.84 | 2021-2025 | Trintellix |
| Adlon Therapeutics L.P. | $38.93 | 2021 | |
| Tempus Ai, INC | $27.97 | 2024 | |
| Lundbeck LLC | $22.62 | 2025 | Rexulti |
| Neurometrix INC | $21.55 | 2023 | |
| Ironshore Pharmaceuticals INC. | $20.48 | 2023 | Jornay Pm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $17.92 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.70 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Durand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.